{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:56:01Z","timestamp":1769597761268,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/igc.0b013e31823532ce","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T04:29:15Z","timestamp":1324528155000},"page":"43-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Extraperitoneal Metastases From Recurrent Ovarian Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"William R.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paiyarut","family":"Kanjanavaikoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31823532ce_bb0005","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin and intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Eng J Med."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Eng J Med."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0020","doi-asserted-by":"crossref","first-page":"s40","DOI":"10.1111\/IGC.0b013e3181bf8143","article-title":"Optimal management of recurrent ovarian cancer","volume":"19","author":"Markman","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0025","first-page":"44","article-title":"Brain metastasis as a late manifestation of ovarian carcinoma","volume":"20","author":"Chen","year":"2011","journal-title":"Eur J Cancer Care."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/IGC.0b013e3181a416d0","article-title":"Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases","volume":"19","author":"Cheng","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1200\/JCO.2002.20.4.982","article-title":"Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence","volume":"20","author":"Kolomainen","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0040","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Burger","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0045","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","article-title":"Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ygyno.2006.05.018","article-title":"The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma","volume":"102","author":"Numnum","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1525-1438.1993.03060359.x","article-title":"Extraperitoneal metastases after intraperitoneal chemotherapy of ovarian cancer patients with a negative second look laparotomy","volume":"3","author":"Menczer","year":"1993","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0060","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1634\/theoncologist.2009-0109","article-title":"Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?","volume":"14","author":"Kobold","year":"2009","journal-title":"Oncologist."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10637-009-9351-4","article-title":"Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review","volume":"28","author":"Bellati","year":"2010","journal-title":"Invest New Drugs."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ygyno.2008.04.028","article-title":"Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer","volume":"111","author":"Hamilton","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823532ce_bb0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"Paez-Ribes","year":"2009","journal-title":"Cancer Cell."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24089023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24089023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31823532ce","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:06Z","timestamp":1753233186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24089023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1048891X24089023"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31823532ce","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraperitoneal Metastases From Recurrent Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31823532ce","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}